Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
722.00    -2.00 (-0.28%)
Bid:
721.00
Ask:
769.00
Spread: 48.00 (6.657%)
Market Cap: £49.10m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Statement re: media speculation

7 Dec 2015 17:36

RNS Number : 2747I
Silver Falcon PLC
07 December 2015
 

7 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

 

Statement regarding media speculation and share price movement

Silver Falcon PLC (LSE: SILF), the Main Board listed special purpose acquisition company set up to acquire businesses in the FinTech space, notes recent press speculation and movements in its share price.

The Company notes that a number of material pieces of information in recent press speculation are factually incorrect and should not be relied upon.

Whilst the Company has had initial discussions with a possible target concerning a possible transaction, all such discussions are at a preliminary stage. No exclusivity agreement or other binding, or non-binding agreements have been entered into with any party, and there is no certainty that any such agreements will be made. A further announcement will be made in due course.

 

 

For further information please contact:

Camarco Tel: +44 (0) 20 3757 4980

Jennifer Renwick / Billy Clegg / Zoё Moulton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGGGWPUPAGMM
Date   Source Headline
27th May 20222:00 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSImmuno-Oncology Summit Europe Presentation
29th Apr 20225:39 pmRNSFinal Results for the Year Ended 31 December 2021
21st Mar 20224:42 pmRNSSecond Price Monitoring Extn
21st Mar 20224:36 pmRNSPrice Monitoring Extension
21st Mar 20222:06 pmRNSSecond Price Monitoring Extn
21st Mar 20222:01 pmRNSPrice Monitoring Extension
16th Mar 20227:00 amRNSCBR Update
4th Mar 20222:05 pmRNSSecond Price Monitoring Extn
4th Mar 20222:00 pmRNSPrice Monitoring Extension
4th Mar 202211:05 amRNSSecond Price Monitoring Extn
4th Mar 202211:00 amRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSHEMO-CAR-T pre-IND Meeting Request
12th Jan 20227:00 amRNSHemogenyx Pharmaceuticals Partnership with Selexis
5th Jan 20227:00 amRNSH.C. Wainwright Bioconnect Conference
22nd Dec 20212:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20212:00 pmRNSPrice Monitoring Extension
22nd Dec 202111:06 amRNSSecond Price Monitoring Extn
22nd Dec 202111:01 amRNSPrice Monitoring Extension
20th Dec 20217:00 amRNSHemo-CAR-T partnership with WuXi ATU
13th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20218:55 amRNSHEMO-CAR-T pre-IND Meeting Request
24th Nov 20212:38 pmRNSConvertible Loans Repayment
18th Oct 20217:00 amRNSLease of New York Mink Building Custom Laboratory
13th Oct 20218:30 amRNSCDX Licence Agreement
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20218:00 amRNSHalf-year Report
2nd Sep 20217:00 amRNSU.S. Approval of Monoclonal Antibody Patent
26th Jul 20217:00 amRNSAppointment of Business Advisor & Board Observer
2nd Jul 202111:23 amRNSCorporate Presentation
25th Jun 20213:32 pmRNSResult of Annual General Meeting
16th Jun 20214:40 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
15th Jun 202112:41 pmRNSChanges to 2021 AGM Arrangements
15th Jun 202111:06 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
2nd Jun 20214:11 pmRNSU.S. Approval and Issuance of CDX Antibody Patent
28th May 20212:00 pmRNSPosting of Annual Report & Notice of AGM
28th May 20218:52 amRNSTotal Voting Rights
27th May 202111:15 amRNSHolding(s) in Company
27th May 202111:15 amRNSHolding(s) in Company
26th May 20217:00 amRNSTermination of Mint Facility; Admission of Shares
19th May 20217:00 amRNSDirector/PDMR Shareholding
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSLoan Notes Sale & Conversion; Facility Terminated
12th May 202112:00 pmRNSPublication of Supplementary Prospectus
12th May 202111:06 amRNSSecond Price Monitoring Extn
12th May 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.